Merck to rebrand
October 16, 2015
MERCK Serono will become
simply Merck in Australia, as
part of a global rebrand which
aims to “reflect the company’s
transformation into a science and
technology company”.
Outside of the US and Canada
the business will operate uniformly
under the name Merck, with the
change accompanied by a new
company logo.
CEO Karl-Ludwig Kley said the
company had fundamentally
changed over the last decade,
developing from a classic supplier
of pharmaceuticals and chemicals
into a global technology operation.
“We are in a position today to
offer solutions to support global
megatrends such as health and
digitisation,” he said”.
Merck Serono will henceforth
operate as the biopharmaceutical
business of Merck, while Merck
Millipore will be the company’s life
science business.
In North America, where the
company does not hold the rights
to the Merck name and brand,
the company will continue to
operate as EMD Serono in the
biopharmaceutical business and
EMD Millipore in the life science
business until the planned
acquisition of Sigma-Aldrich settles.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Oct 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Oct 15
